Haemonetics Corporation Provision for Loan, Lease, and Other Losses
Haemonetics Corporation (HAE) reported Provision for Loan, Lease, and Other Losses of -$280.00 thousand for the 9-month period ending 2022-01-01, per its 10-Q filed 2022-02-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForLoanLeaseAndOtherLosses · last filed 2022-02-08
- Haemonetics Corporation provision for loan, lease, and other losses for the quarter ending 2022-01-01 was -$394.00K, a 114.47% decline year-over-year.
- Haemonetics Corporation provision for loan, lease, and other losses for the quarter ending 2021-10-02 was $658.00K.
- Haemonetics Corporation provision for loan, lease, and other losses for the quarter ending 2021-07-03 was -$544.00K, a 137.47% decline year-over-year.
- Haemonetics Corporation provision for loan, lease, and other losses for the quarter ending 2020-12-26 was $2.72M.
| Period end | Provision for Loan, Lease, and Other Losses 3 month | Provision for Loan, Lease, and Other Losses 3 month as first filed | Provision for Loan, Lease, and Other Losses 6 month | Provision for Loan, Lease, and Other Losses 9 month | Provision for Loan, Lease, and Other Losses 9 month as first filed |
|---|---|---|---|---|---|
| 2022-01-01 | -$394.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-08 | $264.00K derived: sum of 2 quarters · filed 2022-02-08 | -$280.00K 10-Q · filed 2022-02-08 | ||
| 2021-10-02 | $658.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-09 | $114.00K 10-Q · filed 2021-11-09 | |||
| 2021-07-03 | -$544.00K 10-Q · filed 2021-08-11 | ||||
| 2020-12-26 | $2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-08 | $2.33M derived: sum of 2 quarters · filed 2022-02-08 | $3.78M 10-Q · filed 2022-02-08 | $2.94M 10-Q · filed 2021-02-02 | |
| 2020-09-26 | -$395.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-09 | $1.06M 10-Q · filed 2021-11-09 | |||
| 2020-06-27 | $1.45M 10-Q · filed 2021-08-11 | $1.19M 10-Q · filed 2020-08-04 | |||
| 2019-12-28 | -$389.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-02 | -$868.00K derived: sum of 2 quarters · filed 2021-02-02 | -$2.25M 10-Q · filed 2021-02-02 | ||
| 2019-09-28 | -$479.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-04 | -$1.86M 10-Q · filed 2020-11-04 | |||
| 2019-06-29 | -$1.38M 10-Q · filed 2020-08-04 | ||||
| 2018-12-29 | $2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-04 | $3.57M derived: sum of 2 quarters · filed 2020-02-04 | $3.22M 10-Q · filed 2020-02-04 | ||
| 2018-09-29 | $901.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-01 | $549.00K 10-Q · filed 2019-11-01 | |||
| 2018-06-30 | -$352.00K 10-Q · filed 2019-08-06 | ||||
| 2017-12-30 | -$174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-05 | -$414.00K derived: sum of 2 quarters · filed 2019-02-05 | $514.00K 10-Q · filed 2019-02-05 | ||
| 2017-09-30 | -$240.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-06 | $688.00K 10-Q · filed 2018-11-06 | |||
| 2017-07-01 | $928.00K 10-Q · filed 2018-08-07 | ||||
| 2016-12-31 | $4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-06 | $8.83M derived: sum of 2 quarters · filed 2018-02-06 | $11.40M 10-Q · filed 2018-02-06 | ||
| 2016-10-01 | $4.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-07 | $6.90M 10-Q · filed 2017-11-07 | |||
| 2016-07-02 | $2.57M 10-Q · filed 2017-08-07 | ||||
| 2015-12-26 | $4.05M 10-Q · filed 2017-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |